CompletedNot Applicable

Superior Cervical Ganglion Block, Transcranial Doppler

Egypt36 participantsStarted 2020-10-01

Plain-language summary

The aim of this study is to assess blood flow velocity in middle cerebral artery measured by transcranial doppler to determine the efficacy of SCG block in decreasing incidence or severity of vasospasm after MCA aneurysm surgery.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged from 18 to 70 years. * Genders eligible for study: both sexes. * ASA I-II. * GCS (13-15) Exclusion Criteria: * Patient refusal * Contraindications to regional anesthesia (Bleeding disorders, Use of any anti-coagulants, local infection). * Known allergy to local anesthetics. * ASA III-IV. * Patients aged less than 18 or more than 70.

What they're measuring

Change from baseline Blood flow velocity in middle cerebral artery measured by transcranial doppler (TCD)

Timeframe: The day before surgery (TCD0), Postoperative at day 3 and day 7 (TCD3 & TCD7)

Trial details

NCT IDNCT04439760

SponsorFatma Ibrahim El Sayed Salman

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More Brain Aneurysm trials